KPIs & Operating Metrics(New)
Breakdown Of AssetsContractual ObligationsCost Of RevenueDeferred RevenueEmployee StatisticsGross Margin %Gross Margin Annual %Gross ProfitGross Profit AnnualIncome Before Income Tax By RegionLong Lived Assets By GeographyNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Opex As A % Of Total Revenue %OPEX SegregationProperty, Plant And Equipment BreakdownRevenue By Customer'S LocationRevenue By Customer'S Location %Revenue By Geography OmnipodRevenue By Geography Omnipod AnnualRevenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Insulet (PODD) Cost Of Revenue (2016 - 2025)

Insulet filings provide 16 years of Cost of Revenue readings, the most recent being $215.2 million for Q4 2025.

  • On a quarterly basis, Cost of Revenue rose 29.17% to $215.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $768.3 million, a 22.75% increase, with the full-year FY2025 number at $768.2 million, up 22.74% from a year prior.
  • Cost of Revenue hit $215.2 million in Q4 2025 for Insulet, up from $196.2 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $215.2 million in Q4 2025 to a low of $2.4 million in Q4 2021.
  • Median Cost of Revenue over the past 5 years was $144.0 million (2023), compared with a mean of $135.8 million.
  • Biggest five-year swings in Cost of Revenue: crashed 96.48% in 2021 and later skyrocketed 6250.0% in 2022.
  • Insulet's Cost of Revenue stood at $2.4 million in 2021, then skyrocketed by 6250.0% to $152.4 million in 2022, then dropped by 2.49% to $148.6 million in 2023, then rose by 12.11% to $166.6 million in 2024, then grew by 29.17% to $215.2 million in 2025.
  • The last three reported values for Cost of Revenue were $215.2 million (Q4 2025), $196.2 million (Q3 2025), and $196.9 million (Q2 2025) per Business Quant data.